Work

Abstract P5-20-05: A Phase 2 trial of RAD 001 and Carboplatin in patients with triple negative metastatic breast cancer

Year: 2012

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/0008-5472.sabcs12-p5-20-05

Authors: JC Singh, M Volm, Y Novik, J Speyer, S Adams, CO Omene, M Meyers, JA Smith, R Schneider, S Formenti, JD Goldberg, X Li, S Davis, B Beardslee, A Tiersten

Institution: New York University

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2312475897

Cites:

Cited by: 1

Related to: 10